Haisco Pharmaceutical Group Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is 77.12% vs 17.40% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is 1,090.13% vs -48.62% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,564.00",
          "val2": "883.00",
          "chgp": "77.12%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "553.40",
          "val2": "128.80",
          "chgp": "329.66%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "6.80",
          "val2": "8.50",
          "chgp": "-20.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-0.10",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "554.60",
          "val2": "46.60",
          "chgp": "1,090.13%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "353.80%",
          "val2": "71.80%",
          "chgp": "28.20%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 17.82% vs 11.08% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is -44.32% vs 57.71% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "4,346.40",
          "val2": "3,689.10",
          "chgp": "17.82%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "459.10",
          "val2": "406.60",
          "chgp": "12.91%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "32.80",
          "val2": "38.20",
          "chgp": "-14.14%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-5.30",
          "val2": "0.20",
          "chgp": "-2,750.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "259.60",
          "val2": "466.20",
          "chgp": "-44.32%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "40.40%",
          "val2": "41.20%",
          "chgp": "-0.08%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY

Mar'26

Mar'25

Change(%)

Net Sales

1,564.00

883.00

77.12%

Operating Profit (PBDIT) excl Other Income

553.40

128.80

329.66%

Interest

6.80

8.50

-20.00%

Exceptional Items

0.00

-0.10

100.00%

Consolidate Net Profit

554.60

46.60

1,090.13%

Operating Profit Margin (Excl OI)

353.80%

71.80%

28.20%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Mar 2026 is 77.12% vs 17.40% in Mar 2025

Consolidated Net Profit

YoY Growth in quarter ended Mar 2026 is 1,090.13% vs -48.62% in Mar 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

4,346.40

3,689.10

17.82%

Operating Profit (PBDIT) excl Other Income

459.10

406.60

12.91%

Interest

32.80

38.20

-14.14%

Exceptional Items

-5.30

0.20

-2,750.00%

Consolidate Net Profit

259.60

466.20

-44.32%

Operating Profit Margin (Excl OI)

40.40%

41.20%

-0.08%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is 17.82% vs 11.08% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is -44.32% vs 57.71% in Dec 2024

All Annual Results